LLY rides its success against obesity and diabetes LONG

AwesomeAvani Updated   
BATS:LLY   Eli Lilly and Company
LLY shown on a daily chart has doubled in the past year with the introduction of new FDA

approved drugs into the market. It has but out a series of favorable earnings reports with

optimistic realistic guidance and glowing analysts' forecasts. It has done so without any volume

pumps and just keeps grinding higher. This is because it is in the shadows of big technology

stocks. Revenues consistently beat analysts' forecasts quarter after quarter.

Institutions add small lots trying to preserve the price for future buys without any

run-ups. I have done the same thing and I will continue to do so. While day trading

biotechnology penny stocks, LLY along with UNH, PFE, and AZN is where the profits are

parked for growth and compounding.
Zoom-in shows buys at HLs and a sell at a HH since earnings-


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.